+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Severe hypoglycemia during successful treatment of diffuse hemangiomatosis with propranolol

Severe hypoglycemia during successful treatment of diffuse hemangiomatosis with propranolol

Pediatric Dermatology 27(2): 195-196

A 27-day-old male infant with diffuse hemangiomatosis of the skin and liver was treated with oral propranolol at a dosage of 2 mg/kg per day. Five months later skin and liver hemangiomas regressed almost completely. After 160 days of onset of propranolol, the patient presented with seizures on waking up. Laboratory examinations showed blood glucose of 15 mmol (n.v. 50-110) and increased ketone bodies. Propranolol was recommenced at a lower dosage the day after the crisis and then withdrawn when the baby was aged ten months. Hypoglycemia is the most frequent and insidious side effect of propranolol, mainly occurring in circumstances with diminished oral intake. Although the risk appears small, increased vigilance for hypoglycemia in children on chronic propranolol treatment who have decreased caloric intake for any reason seems prudent.

(PDF emailed within 0-6 h: $19.90)

Accession: 055739580

Download citation: RISBibTeXText

PMID: 20537072

DOI: 10.1111/j.1525-1470.2009.01081.x

Related references

Successful treatment of diffuse neonatal hemangiomatosis with propranolol: a case report. Journal der Deutschen Dermatologischen Gesellschaft 12(7): 625-628, 2015

The successful treatment of diffuse neonatal hemangiomatosis with flashlamp pulsed dye laser. Pediatric Dermatology 18(2): 146-148, 2001

Successful treatment with cyclophosphamide of life-threatening diffuse hemangiomatosis involving the liver. Journal of Pediatric Hematology/Oncology 22(6): 527-532, 2000

Isolated diffuse hemangiomatosis of the spleen with disseminated intravascular coagulation: successful treatment with embolization and splenectomy. Journal of Pediatrics 166(4): 1093-10e1, 2015

Diffuse neonatal hemangiomatosis with partial response to propranolol. International Journal of Dermatology 53(4): E247-E250, 2014

Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis. Journal of Pediatrics 157(2): 340-342, 2010

Diffuse neonatal hemangiomatosis successful management with high dose corticosteroids. European Journal of Pediatrics 149(5): 321-324, 1990

Diffuse hemangiomatosis of the spleen: splenic hemangiomatosis presenting with giant splenomegaly, anemia, and thrombocytopenia. American Journal of Gastroenterology 85(11): 1515-1517, 1990

Successful treatment of severe refractory sulfonylurea-induced hypoglycemia with octreotide. Diabetes Care 16(1): 184-186, 1993

Diffuse neonatal hemangiomatosis with severe gastrointestinal involvement. Favorable response to steroid therapy. Clinical Pediatrics 22(8): 589-591, 1983

Usefulness of urgent endoscopic capsule in severe gastrointestinal bleeding due to diffuse intestinal hemangiomatosis. Gastroenterologia Y Hepatologia 36(10): 626-628, 2015

Diffuse neonatal hemangiomatosis treatment with cyclophosphamide: a case report. Journal of Pediatric Hematology/Oncology 31(11): 858-860, 2009

Diffuse neonatal hemangiomatosis: rapid clinical response to treatment with steroids. La Pediatria Medica E Chirurgica 9(4): 483-485, 1987

Successful Hemospray treatment for recurrent diclofenac-induced severe diffuse lower gastrointestinal bleeding avoiding the need for colectomy. Endoscopy 46 Suppl 1 Uctn: E173-E174, 2014

Successful Propranolol Treatment of a Kaposiform Hemangioendothelioma Apparently Resistant to Propranolol. Pediatric Blood & Cancer 63(7): 1290-1292, 2016